Glauconix At Glauconix,   We are contract research organization dedicated to improving the drug discovery and pre-clincal tests in glaucoma for pharmaceutical and biotech companies. Our patented technology allows to mimic the flow within the human trabecular meshwork. This technology implemented against induced glaucoma, can replace current animal and human models to discover new potential theraputics in a cost-effective way.    We are hoping to expand our technology into other disease models, but at the moment, we are dedicated to joining forces with pharmaceutical companies and find more theraputics for glaucoma.   Please contact for any more questions, Rajan Kumar Vice President of Marketing